TRIKAFTA 80mg/40mg/60mg + 59.5mg gran sach 56 pce
7680692120014
CH-69212
R07AX32
03.99.0.
Active substances:
1 / 2
bing
Details
- GTIN
- 7680692120014
- Pharmacode
- -
- Product number
- 6921202
- CPT
- -
- Packaging group
- 56
- Unit
- Sachet(s)
- Composition
- Granulat Morgendosis (elexacaftorum 80 mg / tezacaftorum 40 mg / ivacaftorum 60 mg): elexacaftorum 80 mg, tezacaftorum 40 mg, ivacaftorum 60 mg, hypromellosum, hypromellosi acetas succinas, natrii laurilsulfas, lactosum monohydricum 188.6 mg, mannitolum, carmellosum natricum conexum, sucralosum, magnesii stearas, silica colloidalis anhydrica, ad granulatum pro charta corresp. natrium max. 2.75 mg. Granulat Abenddosis (ivacaftorum 59.5 mg): ivacaftorum 59.5 mg, hypromellosi acetas succinas, natrii laurilsulfas, lactosum monohydricum 87.3 mg, mannitolum, carmellosum natricum conexum, sucralosum, magnesii stearas, silica colloidalis anhydrica, ad granulatum pro charta corresp. natrium max. 1.18 mg.
Articles (1)
Trikafta 80 mg / 40 mg / 60 mg, 59.5 mg, Granulat
Granulat
56
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ivacaftorum
|
59.5 MG | Substance | Wirkstoff (Principe actif) |
|
elexacaftorum
|
80.0 MG | Substance | Wirkstoff (Principe actif) |
|
tezacaftorum
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosi acetas succinas
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
ivacaftorum
|
60.0 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
87.3 MG | Substance | HBESI |
|
hypromellosi acetas succinas
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
lactosum monohydricum
|
188.6 MG | Substance | HBESI |
|
sucralosum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
sucralosum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 14565.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Vertex Pharmaceuticals (CH) GmbH
6300 Zug
Authorization information
- Swissmedic authorization number
- 69212
- Drug name
- Trikafta, Granulat
- Galenic form
- GRB
- ATC Code
- R07AX32
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/06/2024
- Authorization expiration date
- 12/06/2029
- IT number
- 03.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TRIKAFTA 80mg/40mg/60mg + 59.5mg gran sach 56 pce
- Description (DE)
- TRIKAFTA 80mg/40mg/60mg + 59.5mg Gran Btl 56 Stk
- Market launch
- 13/06/2024
- Narcotic (BTM)
- No